Pharmaceuticals, Biotechnology and Life Sciences
A Scalable Model for U.S. Pharmaceutical Security LAKE ZURICH, Ill. & RICHMOND, Va.–(BUSINESS WIRE)–#CommittedToLife–Fresenius Kabi and Phlow Corp. announced today…
This marks the completion of enrollment of all male Phase 3 studies of VDPHL01 in pattern hair loss, with approximately…
LUXEMBOURG–(BUSINESS WIRE)–Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty…
VTx-002 is a first-in-class vectorized antibody to holistically target TDP-43 pathology in ALS recently granted FDA Fast Track Designation for…
EMERYVILLE, Calif.–(BUSINESS WIRE)–#2026TandemMeetings—Estrella Immunopharma, Inc. (Nasdaq: ESLA, ESLAW) (“Estrella” or the “Company”), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted…
Acquisition Expands Unimed’s Netherlands Footprint and Builds on Lagaay Integration NEW YORK–(BUSINESS WIRE)–Universal Maritime Solutions (“Unimed” or “the Company”), a…
Collaboration combines Ethris’ proprietary technology platforms with DZIF’s infectious disease research expertise to advance mRNA-based vaccines across a broad range…
– Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to…
OMNY-AF pilot study reports 90% 12-month freedom from AFib with zero procedure-related adverse eventsi Additional data presented further reinforces the…
The updated edition of the New York Times bestseller from the chair of the Nu Skin Scientific Advisory Board reveals…